TransAct (TACT) CFO reports stock from vesting plus tax withholdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransAct Technologies President and CFO Steven A. DeMartino reported multiple equity-award vesting events and related tax withholdings in late February and early March. On March 1, 2026, Performance Stock Units granted on March 1, 2023 converted into 7,629 shares of common stock, with some shares withheld to cover taxes. Restricted Stock Units granted in 2022, 2023 and 2024 also vested and converted one-for-one into common shares on February 28, March 1, and March 2, 2026. Several Form 4 entries coded “F” show shares delivered back to the company at prices around $3.46–$3.50 solely to satisfy tax or exercise obligations, rather than open-market sales, leaving DeMartino with a remaining direct holding of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
13,229 shares exercised/converted
Mixed
12 txns
Insider
DEMARTINO STEVEN A
Role
President, CFO, Treas. & Secr.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,550 | $0.00 | -- |
| Exercise | Common Stock | 1,550 | $0.00 | -- |
| Tax Withholding | Common Stock | 525 | $3.50 | $2K |
| Exercise | Performance Stock Units | 7,629 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,975 | $0.00 | -- |
| Exercise | Common Stock | 7,629 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,588 | $3.46 | $9K |
| Exercise | Common Stock | 1,975 | $0.00 | -- |
| Tax Withholding | Common Stock | 670 | $3.46 | $2K |
| Exercise | Restricted Stock Units | 2,075 | $0.00 | -- |
| Exercise | Common Stock | 2,075 | $0.00 | -- |
| Tax Withholding | Common Stock | 704 | $3.46 | $2K |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 180,114 shares (Direct);
Performance Stock Units — 0 shares (Direct)
Footnotes (1)
- Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis. Performance Stock Units (PSU) issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended, which vest in three equal installments on March 1, 2024, March 1, 2025 and March 1, 2026 that have converted to common stock on a one-for-one basis. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
FAQ
What did TACT executive Steven DeMartino report on this Form 4?
Steven A. DeMartino reported vesting and conversion of Restricted Stock Units and Performance Stock Units into common stock, plus share dispositions to cover taxes. All awards came from TransAct’s 2014 Equity Incentive Plan under previously granted RSUs and PSUs with scheduled vesting dates.
Which TransAct equity plans were involved in these Form 4 transactions?
All RSUs and PSUs referenced were issued under TransAct Technologies’ 2014 Equity Incentive Plan, as amended and restated. Footnotes specify award grant dates in 2022, 2023 and 2024, along with their scheduled annual or installment vesting schedules converting into common stock.
What vesting schedules applied to the RSUs in this TACT Form 4?
RSUs granted on March 2, 2022, March 1, 2023 and February 29, 2024 each vest 25% annually, starting on the first anniversary of grant. As tranches vested in 2026, they converted into common shares on a one-for-one basis according to the disclosed terms.